Skip to content

Can Music Therapy Improve Noninvasive Ventilation in Acute Exacerbations of COPD?

Effectiveness of music therapy on the efficacy of noninvasive ventilation in acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled clinical trial protocol

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202501862862010
Enrollment
76
Registered
2025-01-31
Start date
2025-01-26
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory

Interventions

Sponsors

Farhat Hached university hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Consecutive adult patients (=18 years) with chronic obstructive pulmonary disease (COPD) admitted to the intensive care unit for an acute exacerbation will be included. Eligibility requires : meeting the GOLD criteria for COPD, having a pH <7.35, and being assessed as suitable for NIV by the attending physician.

Exclusion criteria

Exclusion criteria: - Patients unable to tolerate NIV or for whom NIV is contraindicated - Patients with severe hearing impairment or deafness - Patients for whom life-sustaining therapies have been withdrawn - Patients who have received antidepressant or antipsychotic medications in the previous two months - Aversion of music as assessed by personal interview

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be the efficacy of NIV measured by the reduction in PCO2. This will be calculated as the difference between baseline PCO2 and the PCO2 levels recorded at specific time points during the non-invasive ventilation (NIV) session (h2, h4): ?PCO2=Baseline PCO2 (t0) -Endpoint PCO2 (t1, t2).

Secondary

MeasureTime frame
Secondary Endpoints: • Unplanned interventions: The number of unplanned interventions required by caregivers during the NIV session will be documented. • Changes in respiratory and cardiovascular parameters: These parameters will be assessed before the NIV session, immediately after proper setup (5 minutes), and then at hourly intervals (h1, h2, h3, h4): - Respiratory rate (RR) - Peripheral oxygen saturation (SpO2) - Tidal volume (Vt) - Leak rate - Heart rate (HR) - Systolic blood pressure (SBP) - Diastolic blood pressure (DBP) • Respiratory comfort: assessed using a digital visual scale, changes in respiratory comfort will be measured (h0, h2, h4). • Neurological assessment (h0, h2, h4): - Encephalopathy score (Kelly-Matthay scale) - Glasgow Coma Scale - Richmond Agitation-Sedation Scale (RASS) • Patient-reported outcomes (h0, h2, h4): - Borg Dyspnea Scale (BDS) - Verbal Numeric Rating Scale (VNS) for pain assessment • Psychological assessment (h0, h4): - Rapid Clinical Test For delirium (4 AT) - State Trait Anxiety Inventory (STAI) - Spielberger’s trait anxiety inventory - Perceived stress scale (PSS)

Countries

Tunisia

Contacts

Public ContactImen Ben Saida

Professeur

imen.bensaida@yahoo.com+21622897096

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026